Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

The in vitro effects of antibiotics on cell viability and gene expression of equine bone marrow-derived mesenchymal stromal cells.

Parker RA, Clegg PD, Taylor SE.

Equine Vet J. 2012 May;44(3):355-60. doi: 10.1111/j.2042-3306.2011.00437.x. Epub 2011 Sep 1.

PMID:
21883415
2.

The effects of therapeutic concentrations of gentamicin, amikacin and hyaluronic acid on cultured bone marrow-derived equine mesenchymal stem cells.

Bohannon LK, Owens SD, Walker NJ, Carrade DD, Galuppo LD, Borjesson DL.

Equine Vet J. 2013 Nov;45(6):732-6. doi: 10.1111/evj.12045. Epub 2013 Feb 28.

PMID:
23448189
3.

Influence of commonly used pharmaceutical agents on equine bone marrow-derived mesenchymal stem cell viability.

Edmonds RE, Garvican ER, Smith RK, Dudhia J.

Equine Vet J. 2017 May;49(3):352-357. doi: 10.1111/evj.12590. Epub 2016 Jun 24.

PMID:
27160051
4.

Toxic effects of gentamicin on marrow-derived human mesenchymal stem cells.

Chang Y, Goldberg VM, Caplan AI.

Clin Orthop Relat Res. 2006 Nov;452:242-9.

PMID:
16906089
5.

Priming Equine Bone Marrow-Derived Mesenchymal Stem Cells with Proinflammatory Cytokines: Implications in Immunomodulation-Immunogenicity Balance, Cell Viability, and Differentiation Potential.

Barrachina L, Remacha AR, Romero A, Vázquez FJ, Albareda J, Prades M, Gosálvez J, Roy R, Zaragoza P, Martín-Burriel I, Rodellar C.

Stem Cells Dev. 2017 Jan 1;26(1):15-24. doi: 10.1089/scd.2016.0209. Epub 2016 Nov 3.

PMID:
27712399
6.

Osteogenic differentiation of equine cord blood multipotent mesenchymal stromal cells within coralline hydroxyapatite scaffolds in vitro.

Figueroa RJ, Koch TG, Betts DH.

Vet Comp Orthop Traumatol. 2011;24(5):354-62. doi: 10.3415/VCOT-10-10-0142. Epub 2011 Jul 21.

PMID:
21792475
7.

Pharmacokinetics and pharmacodynamics of enrofloxacin and a low dose of amikacin administered via regional intravenous limb perfusion in standing horses.

Parra-Sanchez A, Lugo J, Boothe DM, Gaughan EM, Hanson RR, Duran S, Belknap JK.

Am J Vet Res. 2006 Oct;67(10):1687-95.

PMID:
17014317
8.

Chondrogenic potential of mesenchymal stromal cells derived from equine bone marrow and umbilical cord blood.

Berg L, Koch T, Heerkens T, Bessonov K, Thomsen P, Betts D.

Vet Comp Orthop Traumatol. 2009;22(5):363-70. doi: 10.3415/VCOT-08-10-0107. Epub 2009 Aug 28.

PMID:
19750290
9.

Activated T cells modulate immunosuppression by embryonic-and bone marrow-derived mesenchymal stromal cells through a feedback mechanism.

Lin W, Oh SK, Choo AB, George AJ.

Cytotherapy. 2012 Mar;14(3):274-84. doi: 10.3109/14653249.2011.635853. Epub 2011 Dec 5.

PMID:
22136295
10.

Differentiation of umbilical cord mesenchymal stem cells into steroidogenic cells in comparison to bone marrow mesenchymal stem cells.

Wei X, Peng G, Zheng S, Wu X.

Cell Prolif. 2012 Apr;45(2):101-10. doi: 10.1111/j.1365-2184.2012.00809.x. Epub 2012 Feb 13.

PMID:
22324479
11.

Comparison of equine tendon- and bone marrow-derived cells cultured on tendon matrix with or without insulin-like growth factor-I supplementation.

Durgam SS, Stewart AA, Pondenis HC, Gutierrez-Nibeyro SM, Evans RB, Stewart MC.

Am J Vet Res. 2012 Jan;73(1):153-61. doi: 10.2460/ajvr.73.1.153.

PMID:
22204302
12.

Migration of culture-expanded human mesenchymal stem cells through bone marrow endothelium is regulated by matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-3.

De Becker A, Van Hummelen P, Bakkus M, Vande Broek I, De Wever J, De Waele M, Van Riet I.

Haematologica. 2007 Apr;92(4):440-9.

14.

Neuronal plasticity of human Wharton's jelly mesenchymal stromal cells to the dopaminergic cell type compared with human bone marrow mesenchymal stromal cells.

Datta I, Mishra S, Mohanty L, Pulikkot S, Joshi PG.

Cytotherapy. 2011 Sep;13(8):918-32. doi: 10.3109/14653249.2011.579957. Epub 2011 Jun 22.

PMID:
21696238
15.

Responses of equine tendon- and bone marrow-derived cells to monolayer expansion with fibroblast growth factor-2 and sequential culture with pulverized tendon and insulin-like growth factor-I.

Durgam SS, Stewart AA, Pondenis HC, Yates AC, Evans RB, Stewart MC.

Am J Vet Res. 2012 Jan;73(1):162-70. doi: 10.2460/ajvr.73.1.162.

PMID:
22204303
16.

PDX1- and NGN3-mediated in vitro reprogramming of human bone marrow-derived mesenchymal stromal cells into pancreatic endocrine lineages.

Limbert C, Päth G, Ebert R, Rothhammer V, Kassem M, Jakob F, Seufert J.

Cytotherapy. 2011 Aug;13(7):802-13. doi: 10.3109/14653249.2011.571248. Epub 2011 Apr 21.

PMID:
21506889
17.

Effects of osteogenic differentiation inducers on in vitro expanded adult mesenchymal stromal cells.

Fiorentini E, Granchi D, Leonardi E, Baldini N, Ciapetti G.

Int J Artif Organs. 2011 Oct;34(10):998-1011. doi: 10.5301/ijao.5000001.

18.

Comparison of chemokine and receptor gene expression between Wharton's jelly and bone marrow-derived mesenchymal stromal cells.

Balasubramanian S, Venugopal P, Sundarraj S, Zakaria Z, Majumdar AS, Ta M.

Cytotherapy. 2012 Jan;14(1):26-33. doi: 10.3109/14653249.2011.605119. Epub 2011 Nov 18.

PMID:
22091833
19.

Effect of various concentrations of antibiotics on osteogenic cell viability and activity.

Rathbone CR, Cross JD, Brown KV, Murray CK, Wenke JC.

J Orthop Res. 2011 Jul;29(7):1070-4. doi: 10.1002/jor.21343. Epub 2011 Feb 24.

20.

Human bone marrow mesenchymal stem cells expressing SDF-1 promote hematopoietic stem cell function of human mobilised peripheral blood CD34+ cells in vivo and in vitro.

Liang X, Su YP, Kong PY, Zeng DF, Chen XH, Peng XG, Zou ZM, Xu H.

Int J Radiat Biol. 2010 Mar;86(3):230-7. doi: 10.3109/09553000903422555.

PMID:
20201651

Supplemental Content

Support Center